The Off-Label Use of Antineoplastics in Oncology Is Limited But Has Notable Scientific Support in a University Hospital Setting

The Off-Label Use of Antineoplastics in Oncology Is Limited But Has Notable Scientific Support in a University Hospital Setting

Purpose: The off-label (OL) use of antineoplastic drugs for the treatment of various types of tumors in patients of different disease stages is becoming a common occurrence. The objective of this study was to analyze these patterns by quantification and characterization of the OL use of antineoplast...

Full description

Bibliographic Details
Main Authors: Marta Herrero Fernandez, Raquel Molina Villaverde, Monica Arroyo Yustos, Fatima Navarro Expósito, Jose Luis Lopez Gonzalez, Maria Rosario Luque Infantes, Melchor Alvarez-Mon Soto
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Pharmacology
Subjects:
off-label use
antineoplastic agents
evidence
prevalence
oncology
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01210/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.01210/full

Similar Items